Improvement effect of lactoferrin and Coenzyme Q10 on body composition of mice with sarcopenia. حسب Wenbin Wu (292223)

الموضوعات:

Weighted Linear Regression Analysis of BRI and ASM/BMI. حسب Wei Huang (36889)

Enrichment analysis of genes from the significant MS module. حسب Lai Jiang (2401513)

الموضوعات:

Compression modulus of improved red clay at 1600 kPa. حسب Quan Shen (37564)

الموضوعات:

Compressive strain of improved red clay at 1600 kPa. حسب Quan Shen (37564)

الموضوعات:

<i>e-lgp</i> curve of improved red clay. حسب Quan Shen (37564)

الموضوعات:

Multivariate linear regression analysis of scales. حسب Xiangyu Wang (341093)

Univariate linear regression analysis of scales. حسب Xiangyu Wang (341093)

Forest plot of the second endpoint of the clinical symptom improvement. حسب Jin-Min Gu (17915039)

الموضوعات:

Voxel-based whole-hemisphere analysis shows regional and dose-dependent decrease of microglia. حسب Francesca Catto (21253435)

Factors associated with the hemoglobin level stratified by age group: Linear regression. حسب Alejandro Rojas Chaves (20614814)

EF-24 treatment significantly reduces cell viability in leukemia cell lines. حسب Ajeet P. Singh (22298432)

الموضوعات:

EF-24 induces significant transcriptional changes in K-562 cells. حسب Ajeet P. Singh (22298432)

الموضوعات:

Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"